Healthcare
Live Price
Offline$17.82
+7.03% today
1Y Change
+69.71%
Window
Jun 20, 2025 → Jun 12, 2026
Coverage: 246 bars · Jun 20, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sensei Biotherapeutics, Inc. (SNSE) is a Healthcare stock with a market cap of $40.00M and listed on NASDAQ. The stock last traded around $17.82 and up 69.7% across the available one-year price window (Jun 20, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -1293.3%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -1293.3%, free cash flow +17.5% with operating margin 459.5% and ROIC -110.9%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SNSE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SNSE
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SNSE Max Drawdown
-69.23%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SNSE and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.